Results

Total Results: 1,229 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_executive.pdf
    January 01, 2012 - care or other interventions without SMBP in its effect on relevant clinical outcomes (cardiovascular events … , mortality, patient satisfaction, quality of life, and adverse events related to antihypertensive … Note: AE = adverse event; BP = blood pressure; CVD = cardiovascular disease; KQ = Key Question; LVH = … , mortality, patient satisfaction, quality of life, and adverse events related to antihypertensive … One quality C trial found no difference in adverse drug reactions across four groups with different
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_executive.pdf
    November 01, 2013 - ; the results also suggest that higher levels of NT-proBNP predicted greater numbers of composite events … and one study did not define a primary endpoint.167 Patients in the BNP/NT-proBNP group had fewer events … The study showed fewer events in the BNP/NT-proBNP group.170 Medications Medication use was reported … failure patients: a multi-marker approach with high-negative predictive value to rule out long- term adverseevents.
  3. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-health-children_research-protocol.pdf
    December 11, 2015 - Published online: December 29, 2014; Updated, December 11, 2015 6 o side effects of intervention (e.g., adverseevents, weight changes, suicidality) o patient dissatisfaction with care 2. … therapeutic relationship • side effects of evidence-based practice incorporated into strategy (e.g., adverseevents, suicidality) • patient dissatisfaction with care 2.
  4. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_executive.pdf
    December 01, 2011 - Although most agents for CDI appear to be well tolerated, explicit reporting of adverse events by treatment … subgroups • Subgroup analysis may include age, gender, comorbid conditions • Explicit reporting of adverseevents KQ 4.
  5. S131 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
    October 01, 2007 - study suggested that the way investigators apply restriction varies substantially when they examine adverse … Studying mixed prevalent and incident user cohorts will lead to under-ascertainment of early events. … Subjects Person-Years Events Event Rate Rate Ratios Unadjusted Age, Sex, Adjusted Multivariate Adjusted … pharmacoepidemiologic analy- ses of prevalent drug users should not be performed because they tend to underascertain events
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
    September 29, 2014 - clinical harms, it is critical to take into account the degree to which polypharmacy characterizes these events … For example, when describing the evidence base for Key Question 2 (Harms and adverse events), the authors … variation in practice” (Page 1, Line 52) and the potential influences of inappropriate practice on poor or adverse … the description of the existing high quality observational studies relating opioid dose to overdose events … Peer Reviewer 11 Introduction Structured abstract (page v): Minor point-- I generally consider adverse
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_executive.pdf
    November 01, 2012 - Key Question 3 What are the harms associated with screening for HCV infection, including adverse effects … What are the harms associated with screening for HCV infection, including adverse effects such as anxiety … chronic HCV infection and compensated cirrhosis with an Ishak fibrosis score of ≥3 reported serious adverseevents in 1.1% of patients, including 0.6% serious bleeds and 0.3% severe pain, with no deaths. … Benefits and adverse effects of hepatitis C screening: early results of a screening program.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/healthcare-infections_disposition-comments.pdf
    August 10, 2015 - all healthcare- associated infections(HAIs) or even multidrug-resistant organism (MDRO) transmission events … that involve environmental surface contamination events. … to a subsequent patient room occupant--these probably account for ~5-10% of all MDRO transmission events … In turn, all MDRO transmission events (or even including non-MDR organism transmission events) have … of microbicidal efficacy e.g. use of quaternary ammonium compounds in mist applications but also adverse
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-outcomes_research-protocol.pdf
    March 03, 2014 - structure of health care delivery system (e.g., colocation of medical and psychiatric care) § Adverse
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_disposition-comments.pdf
    December 01, 2011 - Furthermore, the adverse impacts of ADT monotherapy may be at least as significant (or even more so … incidence is a descriptive measure of the observed population-level density (over person-time) of events … , it can only be based on the observed distribution of events (stratified by disease stage). … In this way, the considerable adverse effects of treatment are at best avoided, and at least deferred … I recommend dividing the discussion of outcomes into disease-specific findings, adverse effects of
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-analogues-disposition-081229.pdf
    September 01, 2008 - long-acting insulins potentially comes at the expense of added patient risk in terms of more hypoglycemic events … ES-2): For adults with type 2 diabetes, do premixed insulin analogues differ in regard to safety, adverse … these methods are appropriate, and caveats are noted (eg inclusion of cross over studies, but not for adverse … glycemic control with pre-mixed compared with long-acting insulin analogues and increased hypoglycemia events … For example, the rate of hypoglycemia events generally i l t t l l f l i t l h d Th t i l th t d t t
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_surveillance.pdf
    January 01, 2013 - The most commonly reported adverse events AEs) were ocular hyperemia and eyelash growth.14 Among … anti-metabolites in a prospective RCT.20 Trabeculectomy with OLO compared with MMC showed no adverse … No adverse reactions were noted.
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
    October 05, 2012 - Studies reporting zero events in one or both arm are excluded from pooling. … outcomes, and this report did look at more patient-centered outcomes, such as mortality and antibiotic adverse … stewardship is recognized, the present evidence does not report on important outcomes such as ABT adverse
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
    March 17, 2020 - What are the harms or adverse events associated with these specific consumer automated-entry PGHD technologies
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
    November 21, 2019 - ) and costs and resource use (use of outpatient clinician services, including palliative care) o Adverse … documentation) and costs and resource use (use of outpatient clinician services, including palliative care) Adverse
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/tinnitus_research-protocol.pdf
    February 22, 2012 - Quality of life o Adverse effects 1. Worsening of tinnitus 2. Sedation 3. … Return to “normal” work o Adverse effects 1. Worsening of tinnitus 2. Sedation 3. … Depression Sleep disturbances Self-reported loudness Quality of life Time until improvement Adverse … In addition to outcomes related to treatment effectiveness, all available data on harms or adverse
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/behavioral-health-screening-disposition-comments.pdf
    April 09, 2025 - Peer Reviewer 1 Methods In the logic model, what do “adverse events, clinician burnout, opportunity … acceptability or feasibility of the implementation approaches utilized nor were patients’ quality of life or adverseevents assessed.” … K., & Children’s Hospital Association Research in Gun Related Events (CHARGE) Collaborative (2024).
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-endocrine-therapy_research.pdf
    August 01, 2012 - and tamoxifen find that up to one-third of women discontinue use within three years of starting.7 Adverse … Both drugs seem to have similar adherence problems despite distinct adverse effect profiles.7,8 Prior
  19. effectivehealthcare.ahrq.gov/products/allergy-seasonal/research
  20. effectivehealthcare.ahrq.gov/products/procalcitonin/research-protocol

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: